Search Results - Nauta, S.T

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Is it cost-effective to use a test to decide which individuals with an intermediate cardiovascular disease risk would benefit from statin treatment?

    Is it cost-effective to use a test to decide which individuals with an intermediate cardiovascular disease risk would benefit from statin treatment? by Burgers, L.T, Nauta, S.T, Deckers, J.W, Severens, J.L, Redekop, W.K

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    CV2 Is It Worth Spending Any Money to Develop a Biomarker Test to Optimize Statin Treatment for Individuals With an Intermediate Cardiovascular Risk?

    CV2 Is It Worth Spending Any Money to Develop a Biomarker Test to Optimize Statin Treatment for Individuals With an Intermediate Cardiovascular Risk? by Burgers, L.T, Nauta, S.T, Deckers, J.W, Severens, J.L, Redekop, W.K

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Risk-benefit in food safety and nutrition – Outcome of the 2019 Parma Summer School

    Risk-benefit in food safety and nutrition – Outcome of the 2019 Parma Summer School by Verhagen, Hans, Alonso-Andicoberry, Cristina, Assunção, Ricardo, Cavaliere, Francesca, Eneroth, Hanna, Hoekstra, Jeljer, Koulouris, Stylianos, Kouroumalis, Andreas, Lorenzetti, Stefano, Mantovani, Alberto, Menozzi, Davide, Nauta, Maarten, Poulsen, Morten, Rubert, Josep, Siani, Alfonso, Sirot, Veronique, Spaggiari, Giulia, Thomsen, Sofie Theresa, Trevisan, Marco, Cozzini, Pietro

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: